Chronic hepatitis B virus infection and dyslipidemia

Journal of the Formosan Medical Association

Volumn 103, Issue 4, 2004, Pages 286-291

  Su, Ta Chen ^a,b   Lee, Yuan Teh ^a   Cheng, Tsun Jen ^a,b   Chien, Hsu Ping ^b   Wang, Jung Der ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Alanine aminotransferase; Dyslipidemia; Hepatitis B virus; Lipoprotein, HDL cholesterol

Indexed keywords

ALANINE AMINOTRANSFERASE; CHOLESTEROL; HEPATITIS B SURFACE ANTIGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ANTHROPOMETRY; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HEALTH CARE PERSONNEL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIFESTYLE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PHYSICAL ACTIVITY; RISK ASSESSMENT; SEX DIFFERENCE; SYMPTOM; BLOOD; HYPERLIPIDEMIA; MIDDLE AGED;

ADULT; AGED; ALANINE TRANSAMINASE; FEMALE; HEPATITIS B, CHRONIC; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED;

EID: 3342994350     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Sung JL, Chen DS, Lai MY, et al: Epidemiological study on hepatitis B virus infection in Taiwan. Chin J Gastroenterol 1984; 1:1-9.
2. Hsu HY, Chang MH, Chen DS, et al: Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before the mass hepatitis B virus vaccination program in Taiwan. J Med Virol 1986:18:301-7.
3. Department of Health, Executive Yuan: Health and Vital Statistics II of the Republic of China, 1999. Taipei, Republic of China.
4. Redeker AG: Viral hepatitis: clinical aspects. Am J Med Sci 1975; 270:9-16.
5. Yu MW, Hsu FC,Sheen IS, et al: Prospective study of hepato-cellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol 1997;145:1039-47.
6. Beasley RP, Lin CC, Hwang LY, et al: Hepatocellular carcinoma and hepatitis B virus. a prospective study of 22,707 men in Taiwan. Lancet 1981;2:1129-33.
7. Kanel GC, Radvan G, Peters RL: High-density lipoprotein cholesterol and liver disease. Hepatology 1983;3:343-8.
8. Cicognani C, Malavolti M, Morselli-Labate AM, et al: Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. Arch Intern Med 1997;157:792-6.
9. Fabris C, Federico E, Soardo G, et al: Blood lipids of patients with chronic hepatitis: differences related to viral etiology. Clin Chim Acta 1997;261:159-65.
10. Chen Z, Keech A, Collins R, et al: Prolonged infection with hepatitis B virus and association between low blood cholesterol concentration and liver cancer. BMJ 1993;306:890-4.
11. Friedewald WT, Levy RI, Fredrickson DS: Estimation of concentration of low density lipoprotein cholesterol in plasma without preparative ultracentrifuge. Clin Chem 1972;18:499-502.
12. Paffenbarger RS, Hyde RT, Wing AL, et al: Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med 1986;314:605-13.
13. Ainsworth BE, Haskel WL, Leon AS, et al: Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 1993;25:71-80.
14. Lee TK, Huang ZS, Ng, SK, et al: Impact of alcohol consumption and cigarette smoking on stroke among the elderly in Taiwan. Stroke 1995;26:790-4.
15. Lien WP, Lai LP, Shyu KG, et al: Low-serum, high-density lipoprotein cholesterol concentration is an important is an important coronary risk factor in Chinese patients with low serum levels of total cholesterol and triglyceride. Am J Cardiol 1996;77:1112-5.
16. Levy RI, Rifkind BM: The structure, function and metabolism of high-density lipoprotients: a status report. Circulation 1980;62 (Suppl IV):4-8.
17. Vergani C, Trovato G, Delu A et al: Serum total lipids, lipoprotein cholesterol, and apolipoprotein A in acute viral hepatitis and chronic liver disease. J Clin Path 1978;31:772-8.
18. Miller VT:Lipids, lipoproteins, women and cardiovascular disease Atherosclerosis 1994;108(Suppl.):573-82.
19. Brown SA, Hutchinson R, Morrisett J, et al: Plasma lipid, lipoprotein cholesterol, and apoprotein distribution in selected US communities. Arteriosler Thromb 1993;13:1139-58.
20. Van Itallie TB: Health implications of overweight and obesity in the United States. Ann Intern Med 1985;103:983-8.
21. Howard BV: Lipoprotein metabolism in diabetes mellitus. J Lipid Res 1987;28:613-28.
22. Torng PL, Su TC, Sung FC, et al: Effects of menopause and obesity on lipid profiles in middle-aged Taiwanese women - The Chin-Shan Community Cardiovascular Cohort Study. Atherosclerosis 2000;153:413-21.
23. Chien KL, Lee YT, Sung FC, et al: Hyperinsulinemia and related atherosclerotic risk factors in the population at risk: community-based study. Clin Chem 1999;45:838-46.
24. Craig WY, Palomaki GE, Haddow JE: Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 1989;298:784-8.
25. Castelli WP, Doyle JT, Gordon T, et al: Alcohol and blood lipids. The Cooperative Phenotying Study. Lancet 1977;2:153-5.
26. Krauss RM: Exercise, lipoproteins, and coronary artery disease. Circulation 1989;79:1143-5.
27. Floren CH, Chen CH, Franzen J, et al: Lecithin: cholesterol acyl-transferase in liver disease. Scand J Clin Invest 1987;47:613-7.
28. Nestel PJ, Tarda N, Fidge NH: Increased catabolism of high-density lipoprotein in alcoholic hepatitis. Metabolism 1980;29:101-4.
29. Grunfeld C, Feingold KR: Tumor necrosis factor, Interleukin, and interferon induced changes in lipid, metabolism as part of host defense. Proc Soc Exp Biol Med 1992;200:224-7.
30. Leong JC, Kane JP, Oleszko O, et al: Antigen specific non-imminoglobulin factor the neutralizes xenotropic virus is associated with mouse serum lipoproteins. Proc Natl Acad Sci USA 1977;74:276-80.
31. Bruckert E, Giral P, Ratziu V, et al: A constellation of cardio-vascular risk factors is associated with hepatic enzyme elevation in hyperlipidemic patients. Metabolism 2002;51:1071-6.
32. Vozarova B, Stefan N, Lidsay RS, et al: High alanine amino-transferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 2002; 51:1889-95.
33. Angelico F, Delben M, Conti R, et al: Non-Alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases. J Gastroenterol Hepatol 2003;18:588-94.
34. National Institutes of Health. Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Bethesda, Md. National Institutes of Health; 2002. NIH Publication 02-5215.
35. Gordon DJ, Rifkind BM: High-density lipoprotein - the clinical implications of recent studies. N Engl J Med 1989;321:1311-6.
36. Rubins HB, Robins SJ, Collins D, et al: Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. N Engl J Med 1999;341:410-8.
37. Wang TD, Lee CM, Wu CC, et al: The effects of dyslipidemia on left ventricular systolic function in patients with stable angina pectoris. Atherosclerosis 1999;146:117-24.
38. Ishizaka N, Ishizaka Y, Takahashi E, et al: Increased prevalence of carotid atherosclerosis in hepatitis B virus carriers. Circulation 2002;105:1028-30.
39. Danesh J, Collins R, Peto R: Chronic infections and coronary heart disease: is there a link? Lancet 1997;350:430-6.
40. Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation 2002;105:1135-43.